Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Cost of Revenue
$446.00K
TTM · Period ending: · USD
LCTX Cost of Revenue
Latest reported$446.00Kperiod ending
Latest reported$446.00Kperiod ending
LCTX Cost of Revenue ($400.00K → $446.00K)
Annual cost of revenue
High-resolution chart · PNG
LCTX cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 845,000 | |
| 334,000 | |
| 671,000 | |
| 728,000 | |
| 1,426,000 | |
| 385,000 | |
| 412,000 | |
| 302,000 | |
| 168,000 | |
| 358,000 | |
| 1,107,000 | |
| 837,052 | |
| 792,659 | |
| 434,271 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -75,458 | |
| -59,540 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 600,000 | |
| 400,000 |